Literature DB >> 1322790

Regulation of intracellular pH in tumor cell lines: influence of microenvironmental conditions.

M J Boyer1, I F Tannock.   

Abstract

The effect of microenvironmental factors on the regulation of intracellular pH (pHi) in MGH U1 cells and EMT-6 cells was studied using the fluorescent pH probe 2',7'-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein. Na+/H+ exchange and Na(+)-dependent Cl-/HCO3- exchange were found to be present in both cell types. The activity of both exchangers was dependent on pHi, with low levels of activity at neutral pH and an increase in activity as pHi fell. The level of extracellular pH (pHe) also influenced the operation of the exchangers, with a fall in activity as pHe was reduced over the range 7.4-6.6. This effect was more marked for the Na(+)-dependent Cl-/HCO3- exchanger than for the Na+/H+ antiporter, suggesting that under conditions of reduced pHe the Na+/H+ antiporter is the major mechanism for regulation of pHi. Neither 6 h of radiobiological hypoxia nor variations in the extracellular [Ca2+] over the range 1-6 mM had an effect on the regulation of pHi, while extracellular lactate (5-10 mM) caused a small, concentration-dependent decrease in the combined activity of both exchangers. We conclude that under the microenvironmental conditions found in some regions of tumors, Na+/H+ exchange may be the major method of regulation of pHi.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1322790

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

1.  Alterations in proteolytic activity at low pH and its association with invasion: a theoretical model.

Authors:  S D Webb; J A Sherratt; R G Fish
Journal:  Clin Exp Metastasis       Date:  1999-07       Impact factor: 5.150

2.  Suppression of Na+/H + exchanger 1 by RNA interference or amiloride inhibits human hepatoma cell line SMMC-7721 cell invasion.

Authors:  Xuekang Yang; Desheng Wang; Wei Dong; Zhenshun Song; Kefeng Dou
Journal:  Med Oncol       Date:  2010-02-12       Impact factor: 3.064

Review 3.  Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression.

Authors:  Lilly Y W Bourguignon
Journal:  Semin Cancer Biol       Date:  2008-03-26       Impact factor: 15.707

4.  The Na+-H+ exchanger-1 induces cytoskeletal changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cells.

Authors:  Angelo Paradiso; Rosa Angela Cardone; Antonia Bellizzi; Anna Bagorda; Lorenzo Guerra; Massimo Tommasino; Valeria Casavola; Stephan J Reshkin
Journal:  Breast Cancer Res       Date:  2004-09-13       Impact factor: 6.466

5.  Selective cellular acidification and toxicity of weak organic acids in an acidic microenvironment.

Authors:  A R Karuri; E Dobrowsky; I F Tannock
Journal:  Br J Cancer       Date:  1993-12       Impact factor: 7.640

6.  Influence of low pH on cytotoxicity of paclitaxel, mitoxantrone and topotecan.

Authors:  V Vukovic; I F Tannock
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  Therapeutic potential of analogues of amiloride: inhibition of the regulation of intracellular pH as a possible mechanism of tumour selective therapy.

Authors:  R P Maidorn; E J Cragoe; I F Tannock
Journal:  Br J Cancer       Date:  1993-02       Impact factor: 7.640

8.  Regulation of intracellular pH in subpopulations of cells derived from spheroids and solid tumours.

Authors:  M J Boyer; M Barnard; D W Hedley; I F Tannock
Journal:  Br J Cancer       Date:  1993-11       Impact factor: 7.640

9.  The chronic administration of drugs that inhibit the regulation of intracellular pH: in vitro and anti-tumour effects.

Authors:  M Yamagata; I F Tannock
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

10.  Inhibition of the regulation of intracellular pH: potential of 5-(N,N-hexamethylene) amiloride in tumour-selective therapy.

Authors:  J Luo; I F Tannock
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.